<p>Conditions to maintain primary tumor cells in culture are largely unknown for most tumor entities including rhabdomyosarcoma. In this collaborative study with Dr. Beat Schäfer's laboratory, we performed DNA methylation profiles of rhabdomyosarcoma patient-derived xenograft (PDX) and their matching PDX-derived primary cells (PPC), where the PPCs were developed and maintained under optimized culture conditions. We further compared DNA methylation profiles between these PDXs and PPCs. Exome sequencing and copy number analysis between these rhabdomyosarcoma PDXs and PPXs were also carried out. These analyses may help us to evaluate a feasibility of <i>in vitro</i> profiling of primary rhabdomyosarcoma cells from a genomic perspective. </p>

DNA Methylation in Rhabdomyosarcoma PDX and PDX-Derived Primary Cells

Rhabdomyosarcoma study with CNV Genotypes, Methylation (CpG) + 1 more data on dbGaP (39 participants)